In Vitro Diagnostics Devices
The U.S. in vitro diagnostics device market is expanding with increased focus on precision medicine, molecular diagnostics, and point-of-care testing. Our research provides detailed insights into market trends, innovation, regulatory developments, and competitive dynamics across the diagnostics landscape.
The U.S. IVD Assay Development Market is projected to grow from USD 1.84 billion in 2025 to USD 4.40 billion by 2035, driven by molecular diagnostics, companion diagnostics, precision oncology, multiplex testing, and advanced biomarker development.
Read Report Details
The U.S. IVD Test Kits Market is projected to grow from $26.65 billion in 2025 to $53.41 billion by 2035, driven by molecular diagnostics, rapid testing, oncology assays, decentralized testing, and expanding home-based diagnostics.
Read Report Details
The U.S. IVD Specimen Collection Devices Market is projected to reach $7.08 billion by 2035, driven by recurring diagnostic testing and decentralized specimen collection.
Read Report Details
The U.S. IVD Sample Preparation Systems Market is projected to grow from $4.92 billion in 2025 to $11.84 billion by 2035 at a 9.18% CAGR, driven by molecular diagnostics, NGS workflows, laboratory automation, and rising demand for high-throughput sample processing.
Read Report Details
The U.S. IVD Controls Market is projected to grow from USD 0.56 billion in 2025 to approximately USD 0.89 billion by 2035 at a 4.74% CAGR, supported by molecular diagnostics, independent quality controls, laboratory automation, and stricter quality management requirements.
Read Report Details
The U.S. IVD Calibrators Market is projected to grow from USD 0.18 billion in 2025 to USD 0.39 billion by 2035 at an 8.15% CAGR, driven by laboratory automation, immunoassay expansion, specialty diagnostics, and rising demand for standardized test accuracy.
Read Report Details
The U.S. IVD Consumables Market is projected to grow from USD 31.20 billion in 2025 to USD 63.41 billion by 2035, supported by recurring diagnostic demand, molecular testing, oncology biomarkers, decentralized diagnostics, and expanding chronic disease monitoring.
Read Report Details
The U.S. IVD Analyzers Market is projected to expand from USD 10.94 billion in 2025 to USD 23.08 billion by 2035, driven by laboratory automation, molecular diagnostics, analyzer replacement cycles, and rising testing volumes.
Read Report Details
The U.S. IVD Instruments Market is projected to grow from USD 9.28 billion in 2025 to USD 18.77 billion by 2035, driven by laboratory automation, analyzer replacement, molecular diagnostics, and decentralized testing.
Read Report Details
The U.S. IVD Reagents Market is projected to grow from USD 23.45 billion in 2025 to USD 47.88 billion by 2035, supported by molecular diagnostics, immunoassays, chronic disease testing, oncology diagnostics, and recurring laboratory reagent demand.
Read Report Details